SI1962895T1 - THERAPEUTIC USE OF A Dll4 ANTAGONIST AND A VEGF INHIBITOR FOR INHIBITING TUMOR GROWTH - Google Patents
THERAPEUTIC USE OF A Dll4 ANTAGONIST AND A VEGF INHIBITOR FOR INHIBITING TUMOR GROWTHInfo
- Publication number
- SI1962895T1 SI1962895T1 SI200631536T SI200631536T SI1962895T1 SI 1962895 T1 SI1962895 T1 SI 1962895T1 SI 200631536 T SI200631536 T SI 200631536T SI 200631536 T SI200631536 T SI 200631536T SI 1962895 T1 SI1962895 T1 SI 1962895T1
- Authority
- SI
- Slovenia
- Prior art keywords
- tumor growth
- therapeutic use
- inhibiting tumor
- vegf inhibitor
- dll4 antagonist
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 108700041286 delta Proteins 0.000 title 1
- 101150109170 dll4 gene Proteins 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 230000004614 tumor growth Effects 0.000 title 1
- 239000002525 vasculotropin inhibitor Substances 0.000 title 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75117305P | 2005-12-16 | 2005-12-16 | |
| US77127606P | 2006-02-08 | 2006-02-08 | |
| US78845606P | 2006-03-31 | 2006-03-31 | |
| US83054306P | 2006-07-12 | 2006-07-12 | |
| EP06848586.1A EP1962895B2 (en) | 2005-12-16 | 2006-12-15 | THERAPEUTIC USE OF A Dll4 ANTAGONIST AND A VEGF INHIBITOR FOR INHIBITING TUMOR GROWTH |
| PCT/US2006/047848 WO2007070671A2 (en) | 2005-12-16 | 2006-12-15 | Therapeutic methods for inhibiting tumor growth with dll4 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1962895T1 true SI1962895T1 (en) | 2013-04-30 |
Family
ID=40206357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200631536T SI1962895T1 (en) | 2005-12-16 | 2006-12-15 | THERAPEUTIC USE OF A Dll4 ANTAGONIST AND A VEGF INHIBITOR FOR INHIBITING TUMOR GROWTH |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN101330925A (en) |
| SI (1) | SI1962895T1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011223919B2 (en) * | 2010-03-02 | 2015-03-19 | Abbvie Inc. | Therapeutic DLL4 binding proteins |
| ES2961713T3 (en) * | 2017-09-29 | 2024-03-13 | Regeneron Pharma | Rodents expressing the humanized C1Q complex |
| CN111234003B (en) * | 2020-02-07 | 2022-02-01 | 中国人民解放军第四军医大学 | Short peptide for cancer targeted therapy, ultrasound response nano drug-loaded microbubble based on short peptide and application of short peptide |
-
2006
- 2006-12-15 CN CNA2006800473723A patent/CN101330925A/en active Pending
- 2006-12-15 SI SI200631536T patent/SI1962895T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101330925A (en) | 2008-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1962895E (en) | Therapeutic use of a dll4 antagonist and a vegf inhibitor for inhibiting tumor growth | |
| EP1753428A4 (en) | Kinase inhibitors as therapeutic agents | |
| IL197933A0 (en) | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases | |
| IL179514A0 (en) | Method of administering and using vegf inhibitors for the treatment of malignant pleural effusion | |
| ZA200704796B (en) | Selecting patients for therapy with a HER inhibitor | |
| EP2026843A4 (en) | Therapeutic uses of inhibitors of rtp801l | |
| EP2063897A4 (en) | Kinase inhibitors useful for the treatment of proliferative diseases | |
| EP2063896A4 (en) | Kinase inhibitors useful for the treatment of proliferative diseases | |
| IL201650A0 (en) | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases | |
| EP2143443A4 (en) | Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener | |
| GB0625659D0 (en) | Therapeutic compounds and their use | |
| IL180411A0 (en) | Quinazolinone derivatives as parp inhibitors | |
| EP2035005A4 (en) | Therapy using cytokine inhibitors | |
| IL182726A0 (en) | 5-heteroaryl thiazoles and their use as p13k inhibitors | |
| PL1999136T3 (en) | Peptidomimetic inhibitors of psma,compounds comprising them, and methods of use | |
| EP1756092A4 (en) | Novel inhibitors of rho-kinases | |
| EP1827391A4 (en) | Dosage forms and methods of use thereof | |
| GB0421525D0 (en) | Inhibitors of protein kineses | |
| EP1809614A4 (en) | Benzotriazine inhibitors of kinases | |
| SI2059246T1 (en) | Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor | |
| ZA200710218B (en) | Mitotic kinesin inhibitors and methods of use thereof | |
| IL206891A0 (en) | Therapeutic inhibitors of pai-1 function and methods of their use | |
| EP1951286A4 (en) | Combined use of dpp iv inhibitors and gastrin compounds | |
| EP1812432A4 (en) | Combination of a src kinase inhibitor and a bcr-abl inhibitor for the treatment of proliferative diseases | |
| GB0422439D0 (en) | Inhibitors of infection |